OBJECTIVE-This study was performed to understand how left ventricular function modulates the prognostic importance of diabetes after myocardial infarction (MI).
D
iabetic patients without myocardial infarction (MI) and MI patients without diabetes have a high and equally adverse long-term risk of cardiovascular death compared with the general population (1,2). As well as diabetes, the presence of systolic dysfunction and heart failure are major risk factors for mortality after MI. A recent study suggested that diabetes may be regarded as a risk equivalent to low left ventricular ejection fraction (LVEF) and that ordinary LVEF risk stratification may not be valid in these patients (3). This study was performed to further clarify their interrelationship.
RESEARCH DESIGN AND METHODS-The current study population comprised Danish patients consecutively screened for entrance in the Trandolapril Cardiac Evaluation (TRACE) study (4) , the Danish Investigations of Arrhythmia and Mortality on Dofetilide Myocardial Infarction (DIAMOND-MI) study (5) , and the Bucindolol Evaluation in Acute MI Trial (BEAT) study (6) . Full study designs have been described previously (4) (5) (6) . In brief, departments participating in any of the studies were required to screen consecutive patients admitted with acute MI. All screenings included a transthoracic echocardiogram, which was analyzed in a core laboratory by independent investigators. LVEF was estimated through a global wall motion index, a nine-segment model in the TRACE study (7) , and a 16-segment model in the DIAMOND-MI and BEAT studies (8) .
This way of obtaining LVEF has a good correlation with outcomes (7) .
All comorbidities including the diagnosis of diabetes were by patient history, patient files, and investigator's determination. The outcome analyzed was the risk of all-cause mortality. Survival status was obtained from the National Population Register on 28 May 2008, giving a maximal observational time of 18 years.
Statistical analysis
Continuous variables were compared with a t test and discrete variables with the x 2 test. Cox proportional hazards models were used for analyses of mortality rates. All models were adjusted for age, sex, LVEF, chronic obstructive pulmonary disease, hypertension, presence of clinical heart failure, a variable indicating the wall motion index scoring system (9 vs. 16 segments), and calendar year of hospitalization. Test for interaction between LVEF and diabetes was done by inclusion of an interaction term in the Cox model with LVEF included as a continuous variable. The relative importance of diabetes was examined independently in patients within defined groups according to LVEF. All analyses were done using SAS version 9.1 (SAS Institute, Cary, NC).
Ethics
All studies were approved by the relevant ethical committees and were conducted in conformity with the Declaration of Helsinki.
RESULTS-A total of 16,912 patients were included in the present analysis. Patients with diabetes were found to be older (69 6 11 [SD] vs. 67 6 12 years), have a lower LVEF (41 6 12 vs. 45 6 12%), a higher frequency of women (38 vs. 30%), a higher prevalence of clinical heart failure (62 vs. 44%), lower creatinine clearance (69 6 1 vs. 72 6 1 mL/min/ 1.73 m 2 ), and higher BMI (26.9 6 0.1 vs. 25.9 6 0.1 kg/m CONCLUSIONS-This study demonstrated that the prognostic importance of diabetes depends on left ventricular function, with diabetes having a stronger negative influence with preserved ventricular function. This result was also found in another study (3) and may appear counterintuitive given the detrimental influence of diabetes in patients with heart failure (9). However, the relationship between diabetes and heart failure is bidirectional, and diabetes may not always contribute causally to the adverse prognosis. For example, it is known that a great proportion of patients with severe heart failure will develop diabetes over time (10) .
Other studies have in accordance with our finding reported the risk of dying from diabetes after MI to be greatest among patients with lowest baseline mortality risk (11) and among patients with mildest coronary artery lesions (12) . In our study, diabetes was associated with a 60% increase in relative risk of mortality among patients with preserved LVEF. Although in the current study it was impossible to investigate what exactly may have driven this increase in risk, complications such as incident heart failure are common over time and are associated with a poor prognosis (13, 14) .
Finally, as previously reported (3), the protective effect on mortality associated with good left ventricular function after MI was found to be attenuated by diabetes, with diabetes conferring a risk equivalent to 10-20% unit depression in LVEF. With regards to prognostic stratification, this is clinically important because predischarge assessment of LVEF should be interpreted differently in patients with diabetes.
Limitations
The diagnosis of diabetes relied on patient history, and oral glucose tolerance tests were not performed on a routine basis. LVEF was estimated by wall motion index, which is observer-dependent and an approximation of LVEF. The current study did not have information on diabetes duration, HbA 1c values, incident diabetes, use of glucose-lowering agents, or diastolic function, which may have influenced outcomes. Finally, the subgroup of patients with LVEF ,25% was small; therefore, a small true increase in HR associated with diabetes cannot be excluded.
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